{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:02:17Z","timestamp":1784775737135,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutions of Health","doi-asserted-by":"crossref","award":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"],"award-info":[{"award-number":["CA240341 to L.Y., CA131332, CA175080, P01 CA087969 to R.M.T., UM1 CA186107 and, to M.S., U01 CA176726 to W.W"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000142","name":"Avon Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen For the Cure","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The insulin-like growth factor (IGF) pathway is implicated in a naturally occurring process of tissue remodeling during which cells acquire stem cell-like characteristics. We examined associations of circulating IGF-1 and IGF binding protein-3 (IGFBP-3) with expression of CD44, CD24, and ALDH1A1 stem cell markers in benign breast biopsies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study included 151 cancer-free women with incident biopsy-confirmed benign breast disease and blood samples within the Nurses\u2019 Health Study II. The data on reproductive and other BCa risk factors were obtained from biennial questionnaires. Immunohistochemistry (IHC) was done on tissue microarrays. For each core, the IHC expression was assessed using QuPath, and expressed as % of cells that stain positively for a specific marker out of the total cell count. Generalized linear regression was used to examine the associations of plasma IGF-I and IGFBP-3 (continuous log-transformed and quartiles) with log-transformed expression of each marker (in epithelium and stroma), adjusted for BCa risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In multivariate analysis, continuous circulating IGF-1 and IGFBP-3 measures were not associated with the continuous expression of any of the markers in the epithelium or stroma. Women whose IGFBP-3 levels were in the top quartile appeared to have lower expression of stromal CD24 compared to those in the lowest quartile (\u03b2\u2009=\u2009\u2212\u20090.38, 95% CI\u2009\u2212\u20090.69,\u2009\u2212\u20090.08, <jats:italic>p<\/jats:italic>-trend\u2009=\u20090.06).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Higher circulating IGFBP-3 levels were associated with lower stromal CD24 expression in benign breast tissue. Our findings provide indirect evidence of the inducing effect of IGF pathway on epithelial-to-mesenchymal transitions and stem cell activity in the breast.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13058-025-02002-z","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T11:43:14Z","timestamp":1744026194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with the expression of stem cell markers in benign breast tissue"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-5340","authenticated-orcid":false,"given":"Lusine","family":"Yaghjyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing J.","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt B.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisey","family":"Ratcliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"2","key":"2002_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12015-008-9012-6","volume":"4","author":"C Cobaleda","year":"2008","unstructured":"Cobaleda C, Cruz JJ, Gonzalez-Sarmiento R, Sanchez-Garcia I, Perez-Losada J. The emerging picture of human breast cancer as a stem cell-based disease. Stem Cell Rev. 2008;4(2):67\u201379.","journal-title":"Stem Cell Rev"},{"issue":"11","key":"2002_CR2","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nrc1212","volume":"3","author":"M Smalley","year":"2003","unstructured":"Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer. 2003;3(11):832\u201344.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2002_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/bcr1385","volume":"8","author":"C-C Chang","year":"2006","unstructured":"Chang C-C. Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res. 2006;8(1):103\u2013103.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2002_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/bcr1741","volume":"9","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Wicha MS. Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res. 2007;9(4):109.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2002_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr3141","volume":"14","author":"MS Rice","year":"2012","unstructured":"Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses\u2019 Health Study II. Breast Cancer Res. 2012;14(2):1\u20137.","journal-title":"Breast Cancer Res"},{"key":"2002_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt207","author":"P Lagiou","year":"2013","unstructured":"Lagiou P, Samoli E, Lagiou A, Zourna P, Barbouni A, Georgila C, Tsikkinis A, Vassilarou D, Minaki P, Sfikas C, et al. A comparison of hormonal profiles between breast cancer and benign breast disease: a case\u2013control study. Ann Oncol. 2013. https:\/\/doi.org\/10.1093\/annonc\/mdt207.","journal-title":"Ann Oncol"},{"issue":"4","key":"2002_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/annonc\/mdu583","volume":"26","author":"E Samoli","year":"2015","unstructured":"Samoli E, Lagiou A, Zourna P, Barbouni A, Georgila C, Tsikkinis A, Vassilarou D, Minaki P, Sfikas C, Spanos E, et al. Expression of estrogen receptors in non-malignant mammary tissue modifies the association between insulin-like growth factor 1 and breast cancer risk. Ann Oncol: Offic J Eur Soc Med Oncol ESMO. 2015;26(4):793\u20137.","journal-title":"Ann Oncol: Offic J Eur Soc Med Oncol ESMO"},{"issue":"1","key":"2002_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ijc.24674","volume":"126","author":"X Su","year":"2010","unstructured":"Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer J Int Cancer. 2010;126(1):180\u201390.","journal-title":"Int J Cancer J Int Cancer"},{"key":"2002_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","volume":"14","author":"PF Christopoulos","year":"2015","unstructured":"Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43.","journal-title":"Mol Cancer"},{"issue":"14","key":"2002_CR10","first-page":"3744","volume":"60","author":"C Byrne","year":"2000","unstructured":"Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Can Res. 2000;60(14):3744\u20138.","journal-title":"Can Res"},{"issue":"3","key":"2002_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1677\/ERC-06-0080","volume":"14","author":"ES Schernhammer","year":"2007","unstructured":"Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer. 2007;14(3):721\u201332.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2002_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-010-1313-1","volume":"128","author":"RM Tamimi","year":"2011","unstructured":"Tamimi RM, Colditz GA, Wang Y, Collins LC, Hu R, Rosner B, Irie HY, Connolly JL, Schnitt SJ. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011;128(1):243\u201350.","journal-title":"Breast Cancer Res Treat"},{"key":"2002_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2015.00059","volume":"6","author":"SM Farabaugh","year":"2015","unstructured":"Farabaugh SM, Boone DN, Lee AV. Role of IGF1R in breast cancer subtypes, stemness, and lineage differentiation. Front Endocrinol. 2015;6:59.","journal-title":"Front Endocrinol"},{"key":"2002_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2014.00010","volume":"5","author":"R Malaguarnera","year":"2014","unstructured":"Malaguarnera R, Belfiore A. The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells. Front Endocrinol. 2014;5:10.","journal-title":"Front Endocrinol"},{"issue":"8","key":"2002_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.humpath.2013.01.005","volume":"44","author":"T Anwar","year":"2013","unstructured":"Anwar T, Kleer CG. Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer. Hum Pathol. 2013;44(8):1457\u201364.","journal-title":"Hum Pathol"},{"key":"2002_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s12032-010-9530-3","volume":"28","author":"A Giatromanolaki","year":"2010","unstructured":"Giatromanolaki A, Sivridis E, Fiska A, Koukourakis M. The CD44+\/CD24\u2212 phenotype relates to \u2018triple-negative\u2019 state and unfavorable prognosis in breast cancer patients. Med Oncol. 2010;28:745.","journal-title":"Med Oncol"},{"issue":"1","key":"2002_CR17","first-page":"481","volume":"2005","author":"BK Abraham","year":"2005","unstructured":"Abraham BK, Fritz P, Van der Kuip H, Buck M, Szabo Z, Athelogou M, Brauch H. Evaluation of CD44+\/CD24-\/low cells in breast cancer and relevance for distant metastasis. AACR Meet Abstracts. 2005;2005(1):481.","journal-title":"AACR Meet Abstracts"},{"issue":"5","key":"2002_CR18","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.2353\/ajpath.2010.090712","volume":"176","author":"V Neumeister","year":"2010","unstructured":"Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol. 2010;176(5):2131\u20138.","journal-title":"Am J Pathol"},{"issue":"5","key":"2002_CR19","first-page":"1149","volume":"22","author":"JH Lee","year":"2009","unstructured":"Lee JH, Kim SH, Lee ES, Kim YS. CD24 overexpression in cancer development and progression: a meta-analysis. Oncol Rep. 2009;22(5):1149\u201356.","journal-title":"Oncol Rep"},{"issue":"4","key":"2002_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/gme.0b013e3181d3cdd7","volume":"17","author":"JA Eden","year":"2010","unstructured":"Eden JA. Human breast cancer stem cells and sex hormones\u2013a narrative review. Menopause. 2010;17(4):801\u201310.","journal-title":"Menopause"},{"issue":"5","key":"2002_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555\u201367.","journal-title":"Cell Stem Cell"},{"key":"2002_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/1471-2407-14-444","volume":"14","author":"Y Liu","year":"2014","unstructured":"Liu Y, Lv DL, Duan JJ, Xu SL, Zhang JF, Yang XJ, Zhang X, Cui YH, Bian XW, Yu SC. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis. BMC Cancer. 2014;14:444.","journal-title":"BMC Cancer"},{"issue":"3","key":"2002_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/modpathol.2011.172","volume":"25","author":"T Khoury","year":"2012","unstructured":"Khoury T, Ademuyiwa FO, Chandraseekhar R, Jabbour M, DeLeo A, Ferrone S, Wang Y, Wang X. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy. Mod Pathol. 2012;25(3):388\u201397.","journal-title":"Mod Pathol"},{"issue":"25","key":"2002_CR24","doi-asserted-by":"publisher","first-page":"e7171","DOI":"10.1097\/MD.0000000000007171","volume":"96","author":"J Yao","year":"2017","unstructured":"Yao J, Jin Q. Wang X-d, Zhu H-j, Ni Q-c: Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer. Medicine. 2017;96(25):e7171.","journal-title":"Medicine"},{"issue":"15","key":"2002_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jnci\/djm062","volume":"99","author":"RM Tamimi","year":"2007","unstructured":"Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):1178\u201387.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2002_CR26","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/cncr.22136","volume":"107","author":"LC Collins","year":"2006","unstructured":"Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses\u2019 Health Study. Cancer. 2006;107(6):1240\u20137.","journal-title":"Cancer"},{"issue":"4","key":"2002_CR27","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res. 2006;66(4):2476\u201382.","journal-title":"Cancer Res"},{"issue":"2","key":"2002_CR28","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/bcr3141","volume":"14","author":"MS Rice","year":"2012","unstructured":"Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses\u2019 Health Study II. Breast Cancer Res. 2012;14(2):R44.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2002_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1309\/UP07-K3KD-25NL-D3M8","volume":"115","author":"TW Jacobs","year":"2001","unstructured":"Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Pathologic features of breast cancers in women with previous benign breast disease. Am J Clin Pathol. 2001;115(3):362\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2002_CR30","doi-asserted-by":"publisher","first-page":"R555","DOI":"10.1186\/bcr1039","volume":"7","author":"RM Tamimi","year":"2005","unstructured":"Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case\u2013control study. Breast Cancer Res. 2005;7(4):R555.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"2002_CR31","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer. 1985;55(11):2698\u2013708.","journal-title":"Cancer"},{"issue":"5","key":"2002_CR32","first-page":"438","volume":"17","author":"LC Collins","year":"2009","unstructured":"Collins LC, Wang YH, Connolly JL, Baer HJ, Hu R, Schnitt SJ, Colditz GA, Tamimi RM. potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohisto M M. 2009;17(5):438\u201341.","journal-title":"Appl Immunohisto M M"},{"key":"2002_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1040061","author":"L Yaghjyan","year":"2022","unstructured":"Yaghjyan L, Heng YJ, Baker GM, Bret-Mounet V, Murthy D, Mahoney MB, Mu Y, Rosner B, Tamimi RM. Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: pathologist assessment compared to quantitative image analysis. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.1040061.","journal-title":"Front Med"},{"issue":"1","key":"2002_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13058-017-0889-3","volume":"19","author":"L Yaghjyan","year":"2017","unstructured":"Yaghjyan L, Stoll E, Ghosh K, Scott CG, Jensen MR, Brandt KR, Visscher D, Vachon CM. Tissue-based associations of mammographic breast density with breast stem cell markers. Breast Cancer Res BCR. 2017;19(1):100\u2013100.","journal-title":"Breast Cancer Res BCR"},{"issue":"10","key":"2002_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10552-019-01207-w","volume":"30","author":"L Yaghjyan","year":"2019","unstructured":"Yaghjyan L, Esnakula AK, Scott CG, Wijayabahu AT, Jensen MR, Vachon CM. Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes. Cancer Causes Control. 2019;30(10):1103\u201311.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2002_CR36","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"key":"2002_CR37","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.jpi.2022.100118","volume":"13","author":"GM Baker","year":"2022","unstructured":"Baker GM, Bret-Mounet VC, Wang T, Veta M, Zheng H, Collins LC, Eliassen AH, Tamimi RM, Heng YJ. Immunohistochemistry scoring of breast tumor tissue microarrays: a comparison study across three software applications. J Pathol Inform. 2022;13:100118.","journal-title":"J Pathol Inform"},{"issue":"6","key":"2002_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a113598","volume":"117","author":"W Willett","year":"1983","unstructured":"Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117(6):651\u20138.","journal-title":"Am J Epidemiol"},{"issue":"17","key":"2002_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","volume":"313","author":"MJ Stampfer","year":"1985","unstructured":"Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal Estrogen therapy and coronary heart disease. N Engl J Med. 1985;313(17):1044\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"2002_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/aje\/kwm348","volume":"167","author":"B Rosner","year":"2008","unstructured":"Rosner B, Cook N, Portman R, Daniels S, Falkner B. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol. 2008;167(6):653\u201366.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2002_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/wdev.35","volume":"1","author":"H Macias","year":"2012","unstructured":"Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol. 2012;1(4):533\u201357.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"3","key":"2002_CR42","first-page":"239","volume":"1","author":"CI Chang","year":"2012","unstructured":"Chang CI, Low HP, Qiu L, Strohsnitter WC, Hsieh CC. Prenatal modulation of breast density and breast stem cells by insulin-like growth factor-1. Am J Stem Cells. 2012;1(3):239\u201352.","journal-title":"Am J Stem Cells"},{"issue":"7","key":"2002_CR43","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1158\/0008-5472.CAN-15-1927","volume":"76","author":"SJ Huh","year":"2016","unstructured":"Huh SJ, Oh H, Peterson MA, Almendro V, Hu R, Bowden M, Lis RL, Cotter MB, Loda M, Barry WT, et al. The proliferative activity of mammary epithelial cells in normal tissue predicts breast cancer risk in premenopausal women. Can Res. 2016;76(7):1926\u201334.","journal-title":"Can Res"},{"key":"2002_CR44","doi-asserted-by":"publisher","first-page":"16032","DOI":"10.1038\/npjbcancer.2016.32","volume":"2","author":"H Oh","year":"2016","unstructured":"Oh H, Eliassen AH, Wang M, Smith-Warner SA, Beck AH, Schnitt SJ, Collins LC, Connolly JL, Montaser-Kouhsari L, Polyak K, et al. Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer. NPJ Breast Cancer. 2016;2:16032.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"2002_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41523-017-0041-7","volume":"3","author":"H Oh","year":"2017","unstructured":"Oh H, Eliassen AH, Beck AH, Rosner B, Schnitt SJ, Collins LC, Connolly JL, Montaser-Kouhsari L, Willett WC, Tamimi RM. Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue. NPJ Breast Cancer. 2017;3(1):39.","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"2002_CR46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.stemcr.2018.03.001","volume":"10","author":"JA Colacino","year":"2018","unstructured":"Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, Lee M, Hill D, Madden J, Boerner J, et al. Heterogeneity of human breast stem and progenitor cells as revealed by transcriptional profiling. Stem Cell Reports. 2018;10(5):1596\u2013609.","journal-title":"Stem Cell Reports"},{"issue":"11","key":"2002_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo S, Vieira AF, Gerhard R, Leit\u00e3o D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol. 2011;64(11):937\u201346.","journal-title":"J Clin Pathol"},{"issue":"8","key":"2002_CR48","first-page":"e28056","volume":"14","author":"L Escudero Mendez","year":"2022","unstructured":"Escudero Mendez L, Srinivasan M, Hamouda RK, Ambedkar B, Arzoun H, Sahib I, Fondeur J, Mohammed L. Evaluation of CD44+\/CD24- and aldehyde dehydrogenase enzyme markers in cancer stem cells as prognostic indicators for triple-negative breast cancer. Cureus. 2022;14(8):e28056.","journal-title":"Cureus"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02002-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:40:21Z","timestamp":1744191621000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02002-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02002-z","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review boards of the Brigham and Women\u2019s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required. Consent was obtained or implied by return of questionnaires.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All funding sources have been acknowledged. There are no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}